We turn science
into medicine.

Angiolutions

stops

aortic aneurysms.

An abdominal aortic aneurysm (AAA) is a local “ballooning” of the aorta – the biggest blood vessel in the human body.

AAA is a frequent disease, affecting up to 5% of the population.

AAAs are progressive in nature – that means, AAAs become larger over time and may eventually rupture.

AAA rupture is lethal
in most cases.

To date, there is no treatment to stop AAA progression.

A

bdominal

A

ortic

A

neurysm

Technology

A new understanding of AAA growth mechanisms

What causes aneurysms to grow?

Pulse waves are generated with every heartbeat and run down the aorta

Pulse waves hit the susceptible AAA and mechanically drive AAA growth

And how can we stop the growth?

Angiolutions device absorbs aortic pulse waves and mechanically shields the AAA

AAA is protected from aortic pulse waves and stops growing 

Angiolutions: first device to stop AAA progression

About us

Angiolutions’ leadership team: Co-founders and Co-CEOs Dr. Uwe Raaz & Dr. Isabel N. Schellinger and Chief Business Officer Marius Rummel. Together, they lead a diverse, interdisciplinary team that is complemented by a board of industry veterans, top clinicians and leading researchers.

Traction

Forbes - 30 under 30

TMC X Companies

Jörg-Vollmar-Award

MIT Technology Review

Winner MedTech Bootcamp

1st Prize World IP Day Competition

Winner CSI Innovation Award

€2.5m EIC Accelerator grant

Previous slide
Next slide

Stay in touch

receive update emails a few times a year

stay in touch

Contact

Please leave your message here

contact